, Tracking Stock Market Picks
Enter Symbol:
Nuvasive, Inc. (NUVA) [hlAlert]

up 37.90 %

Nuvasive, Inc. (NUVA) upgraded to Outperform with price target $45 by Leerink Swann

Posted on: Wednesday,  Jan 22, 2014  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Nuvasive, Inc. (NASDAQ: NUVA) on 01/22/2014, when the stock price was $38.25. Since
then, Nuvasive, Inc. has gained 37.91% as of 01/25/2016's recent price of $52.75.
If you would have followed this Leerink Swann 's recommendation on NUVA, you would have gained 37.9% of your investment in 733 days.

Nuvasive Inc

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/22/2014 8:25 AM Buy
38.25 45.00
as of 10/17/2014
1 Week down  -0.05 %
1 Month down  -6.52 %
3 Months up  6.25 %
1 YTD down  -9.77 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/25/2012 8:25 AM Hold
3/30/2009 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy